SmartZyme BioPharma
Latest round
- Series B
Last raised
- Mar 2018
Total raised
- Undisclosed
Investors
- 2
About SmartZyme BioPharma
SmartZyme BioPharma, Inc.Founded in 2013, SmartZyme BioPharma, Inc. is headquartered in New York, US. The company focuses on glycan-based therapeutics and bioconjugation technologies.SmartZyme BioPharma, Ltd. specializes in developing glycan-based therapeutics and bioconjugation technologies, focusing on glycobiology. Their core offerings include assay kits, enzymes, and recombinant proteins aimed at facilitating glycoproteomic analysis and vaccine development.SmartZyme BioPharma operates a B2B business model, generating revenue through direct sales of specialized products such as assay kits and enzymes, sold individually or in bulk to institutional clients. The company may also form partnerships that provide exclusive access to certain technologies, increasing market reach and customer loyalty. The company is developing new products focused on glycan-based therapeutics, which are anticipated to enhance their offerings. Additionally, SmartZyme aims to penetrate new markets across Europe and Asia by the end of 2023, broadening its geographic footprint and customer base.
Who invested in SmartZyme BioPharma
2 investors across 1 round
See all investors in SmartZyme BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 14, 2018
Amount
Undisclosed
Investors
Questions about SmartZyme BioPharma
Who invested in SmartZyme BioPharma?
SmartZyme BioPharma has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SmartZyme BioPharma raised?
SmartZyme BioPharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SmartZyme BioPharma last raise money?
SmartZyme BioPharma's most recent round on record is a Series B, in Mar 2018.
What does SmartZyme BioPharma do?
SmartZyme BioPharma is a biotechnology company.
Where is SmartZyme BioPharma headquartered?
SmartZyme BioPharma is headquartered in New York, US.
Which VCs invest in companies like SmartZyme BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SmartZyme BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like SmartZyme BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.